Trial intelligence / Profile preview

Effect of food on pharmacokinetics and pharmacodynamics of desmopressin tablet versus desmopressin MELT in children with monosymptomatic nocturnal enuresis

2009-017265-33Phase 3Completed

Sponsor
Ghent University Hospital
Start
Dec 2009
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3 trial of desmopressin in Monosymptomatic nocturnal enuresis (MNE) and nocturnal polyuria (NP) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Reduction in urine production. Started Dec 2009; status: completed.

02

Drugs

desmopressin
03

Conditions

Monosymptomatic nocturnal enuresis (MNE)nocturnal polyuria (NP)

Beyond the preview

Go deeper on 2009-017265-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017265-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call